DUBLIN, Ohio, Jan. 12, 2016 /PRNewswire/ -- Cardinal
Health's Chairman and CEO George S.
Barrett will be presenting at the J.P. Morgan Healthcare
Conference in San Francisco today
at 9:30 a.m. Pacific time.
Related to this presentation, the company is reaffirming its fiscal
2016 non-GAAP diluted earnings per share (EPS)1 guidance
of $5.15 to $5.35, representing an 18
to 22 percent growth rate compared to fiscal 2015.
Both the presentation and question-and-answer session will be
live-webcast, with replays available, at
ir.cardinalhealth.com/events/.
Footnote (1) Non-GAAP diluted earnings per share
(EPS): (A) net earnings attributable to Cardinal Health,
excluding (1) restructuring and employee severance, (2)
amortization and other acquisition-related costs, (3) impairments
and (gain)/loss on disposal of assets, (4) litigation
(recoveries)/charges, net, (5) LIFO charges/(credits), and (6) loss
on extinguishment of debt, each net of tax, (B) divided by diluted
weighted average shares outstanding.
Cardinal Health presents non-GAAP diluted earnings per share on
a forward-looking basis. The most directly comparable
forward-looking GAAP measure is diluted earnings per share
attributable to Cardinal Health. Cardinal Health is unable to
provide a quantitative reconciliation of this forward-looking
non-GAAP measure to the most directly comparable forward-looking
GAAP measure, because Cardinal Health cannot reliably forecast
restructuring and employee severance, amortization and
acquisition-related costs, impairments and (gain)/loss on disposal
of assets, litigation (recoveries)/charges, net, LIFO
charges/(credits), and loss on extinguishment of debt, which are
difficult to predict and estimate. Please note that the unavailable
reconciling items could significantly impact Cardinal Health's
future financial results.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE:
CAH) is a $103 billion health care
services company that improves the cost-effectiveness of health
care. Cardinal Health helps pharmacies, hospitals, ambulatory
surgery centers, clinical laboratories and physician offices focus
on patient care while reducing costs, enhancing efficiency and
improving quality. Cardinal Health is an essential link in the
health care supply chain, providing pharmaceuticals and medical
products and services to more than 100,000 locations each day and
is also the industry-leading direct-to-home medical supplies
distributor. The company is a leading manufacturer of medical and
surgical products, including gloves, surgical apparel and fluid
management products. In addition, the company operates the nation's
largest network of radiopharmacies that dispense products to aid in
the early diagnosis and treatment of disease. Ranked #26 on the
Fortune 500, Cardinal Health employs more than 36,000 people
worldwide. More information about the company may be found at
www.cardinalhealth.com and @CardinalHealth on Twitter.
Cautions Concerning Forward-Looking Statements
This
news release contains forward-looking statements addressing
expectations, prospects, estimates and other matters that are
dependent upon future events or developments. These statements may
be identified by words such as "expect," "anticipate," "intend,"
"plan," "believe," "will," "should," "could," "would," "project,"
"continue," "likely," and similar expressions, and include
statements reflecting future results or guidance, statements of
outlook and expense accruals. These matters are subject to risks
and uncertainties that could cause actual results to differ
materially from those projected, anticipated or implied. These
risks and uncertainties include competitive pressures in Cardinal
Health's various lines of business; the ability to continue to
achieve and maintain the benefits from the generic sourcing
venture with CVS Health; the ability to achieve and
maintain the benefits from the acquisitions of Cordis and The
Harvard Drug Group; the frequency or rate of pharmaceutical price
appreciation or deflation and the timing of generic and branded
pharmaceutical introductions; the risk of non-renewal or a default
under one or more key customer or supplier arrangements or changes
to the terms of or level of purchases under those arrangements;
uncertainties due to government health care reform, including
federal health care reform legislation; changes in the distribution
patterns or reimbursement rates for health care products and
services; the effects of any investigation or action by any
regulatory authority; and changes in the cost of commodities such
as oil-based resins, cotton, latex and diesel fuel. Cardinal Health
is subject to additional risks and uncertainties described in
Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and
exhibits to those reports. This news release reflects management's
views as of Jan. 12, 2016. Except to
the extent required by applicable law, Cardinal Health undertakes
no obligation to update or revise any forward-looking
statement.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cardinal-health-reaffirms-fiscal-2016-non-gaap-diluted-earnings-per-share-guidance-300202763.html
SOURCE Cardinal Health